BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37623030)

  • 1. An Overview of Pancreatic Neuroendocrine Tumors and an Update on Endoscopic Techniques for Their Management.
    Elkelany OO; Karaisz FG; Davies B; Krishna SG
    Curr Oncol; 2023 Aug; 30(8):7566-7580. PubMed ID: 37623030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: A Systematic Review and Metanalysis.
    Armellini E; Facciorusso A; Crinò SF
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837560
    [No Abstract]   [Full Text] [Related]  

  • 3. Endoscopic ablation therapy for the pancreatic neoplasms.
    Matsumoto K; Kato H
    Dig Endosc; 2023 May; 35(4):430-442. PubMed ID: 36366955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of the role of endoscopy in evaluation and management of gastrointestinal and pancreatic neuroendocrine tumors.
    Nabi Z; Lakhtakia S; Reddy DN
    Indian J Gastroenterol; 2023 Apr; 42(2):158-172. PubMed ID: 37129761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.
    Marx M; Godat S; Caillol F; Poizat F; Ratone JP; Pesenti C; Schoepfer A; Hoibian S; Dahel Y; Giovannini M
    Dig Endosc; 2022 Sep; 34(6):1207-1213. PubMed ID: 34963025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgery.
    Law JK; Singh VK; Khashab MA; Hruban RH; Canto MI; Shin EJ; Saxena P; Weiss MJ; Pawlik TM; Wolfgang CL; Lennon AM
    Surg Endosc; 2013 Oct; 27(10):3921-6. PubMed ID: 23636530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic Ultrasound-Guided Therapies in Patients with Pancreatic Neuroendocrine Tumors.
    Morgan AD; Ramai D; Bandaru P; Crino SF; Facciorusso A
    Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1355-1358. PubMed ID: 37055906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and predictive factors of endoscopic ultrasound-guided ethanol ablation in benign solid pancreatic tumors.
    Choi JH; Paik WH; Lee SH; Lee MW; Cho IR; Ryu JK; Kim YT
    Surg Endosc; 2023 Aug; 37(8):5960-5968. PubMed ID: 37079095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic ultrasound-guided radiofrequency ablation for management of benign solid pancreatic tumors.
    Choi JH; Seo DW; Song TJ; Park DH; Lee SS; Lee SK; Kim MH
    Endoscopy; 2018 Nov; 50(11):1099-1104. PubMed ID: 29727904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic ultrasound-guided ethanol ablation therapy for tumors.
    Zhang WY; Li ZS; Jin ZD
    World J Gastroenterol; 2013 Jun; 19(22):3397-403. PubMed ID: 23801831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors.
    Papaefthymiou A; Laskaratos FM; Koffas A; Manolakis A; Gkolfakis P; Coda S; Sodergren M; Suzuki N; Toumpanakis C
    Curr Treat Options Oncol; 2022 Jul; 23(7):1014-1034. PubMed ID: 35511346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic ultrasound guided radiofrequency ablation for pancreatic tumors: A critical review focusing on safety, efficacy and controversies.
    Khoury T; Sbeit W; Napoléon B
    World J Gastroenterol; 2023 Jan; 29(1):157-170. PubMed ID: 36683710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions.
    Karaisz FG; Elkelany OO; Davies B; Lozanski G; Krishna SG
    Diagnostics (Basel); 2023 Feb; 13(3):. PubMed ID: 36766643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study.
    Barthet M; Giovannini M; Lesavre N; Boustiere C; Napoleon B; Koch S; Gasmi M; Vanbiervliet G; Gonzalez JM
    Endoscopy; 2019 Sep; 51(9):836-842. PubMed ID: 30669161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
    Farrell JM; Pang JC; Kim GE; Tabatabai ZL
    Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic techniques for diagnosis and treatment of gastro-entero-pancreatic neuroendocrine neoplasms: Where we are.
    Rossi RE; Elvevi A; Gallo C; Palermo A; Invernizzi P; Massironi S
    World J Gastroenterol; 2022 Jul; 28(26):3258-3273. PubMed ID: 36051341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic ultrasound-guided ethanol and radiofrequency ablation of pancreatic insulinomas: a systematic literature review.
    El Sayed G; Frim L; Franklin J; McCrudden R; Gordon C; Al-Shamma S; Kiss S; Hegyi P; Erőss B; Hegyi PJ
    Therap Adv Gastroenterol; 2021; 14():17562848211042171. PubMed ID: 34819995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumor.
    Barthet M
    Ann Endocrinol (Paris); 2019 Jun; 80(3):182-184. PubMed ID: 31053252
    [No Abstract]   [Full Text] [Related]  

  • 19. The safety and efficacy of endoscopic ultrasound-guided ablation therapy for solid pancreatic tumors: a systematic review.
    Zhang L; Tan S; Huang S; Zhong C; Lü M; Peng Y; Tang X
    Scand J Gastroenterol; 2020 Sep; 55(9):1121-1131. PubMed ID: 32730715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EUS-guided ablation of pancreatic neoplasms.
    Rimbaș M; Rizzatti G; Larghi A
    Minerva Gastroenterol (Torino); 2022 Jun; 68(2):186-201. PubMed ID: 33871223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.